Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 38, 2023 - Issue 1
Submit an article Journal homepage
1,618
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII

Ashraf K. El-Damasya Center for Brain Technology, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, South Korea;b Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, EgyptCorrespondence[email protected] [email protected]
View further author information
,
Hyun Ji Kima Center for Brain Technology, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, South KoreaView further author information
,
Alessio Nocentinic Section of Pharmaceutical and Nutraceutical Sciences, Department of NEUROFARBA, University of Florence, Florence, Italy;d Laboratory of Molecular Modeling Cheminformatics & QSAR, Department of NEUROFARBA-Pharmaceutical and Nutraceutical Section, University of Firenze, Florence, ItalyORCID Iconhttps://orcid.org/0000-0003-3342-702XView further author information
ORCID Icon,
Seon Hee Seoa Center for Brain Technology, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, South KoreaView further author information
,
Wagdy M. Eldehnae Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafr El Sheikh, EgyptORCID Iconhttps://orcid.org/0000-0001-6996-4017View further author information
ORCID Icon,
Eun-Kyoung Banga Center for Brain Technology, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, South KoreaView further author information
,
Claudiu T. Supuranc Section of Pharmaceutical and Nutraceutical Sciences, Department of NEUROFARBA, University of Florence, Florence, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4262-0323View further author information
ORCID Icon &
Gyochang Keuma Center for Brain Technology, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, South Korea;f Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Seoul, South KoreaCorrespondence[email protected]
View further author information
 show all
Article: 2154603 | Received 20 Oct 2022, Accepted 30 Nov 2022, Published online: 02 Feb 2023

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Claudiu T Supuran. (2023) Targeting carbonic anhydrases for the management of hypoxic metastatic tumors. Expert Opinion on Therapeutic Patents 33:11, pages 701-720.
Read now

Articles from other publishers (7)

Samer Tareq Jasim & Monther F. Mahdi. (2024) Molecular Modeling, Synthesis, and preliminary pharmacological evaluation of New Sulfonamide Derivatives as Selective Carbonic Anhydrase XII and IX inhibitors (Research). Al Mustansiriyah Journal of Pharmaceutical Sciences 24:2, pages 137-149.
Crossref
Sridhar Goud Nerella, Pavitra S. Thacker, Mohammed Arifuddin & Claudiu T. Supuran. (2024) Tumor associated carbonic anhydrase inhibitors: Rational approaches, design strategies, structure activity relationship and mechanistic insights. European Journal of Medicinal Chemistry Reports 10, pages 100131.
Crossref
Ashraf K. El-Damasy, Hyun Ji Kim, Ahmed A. Al-Karmalawy, Radwan Alnajjar, Mohamed M. Khalifa, Eun-Kyoung Bang & Gyochang Keum. (2024) Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals 17:4, pages 427.
Crossref
Gönül Yapar, Nebih Lolak, Alessandro Bonardi, Suleyman Akocak & Claudiu T. Supuran. (2024) Exploring the potency of diazo‐coumarin containing hybrid molecules: Selective inhibition of tumor‐associated carbonic anhydrase isoforms IX and XII. ChemMedChem 19:4.
Crossref
Ashraf K. El-Damasy, Jong Min Oh, Hyun Ji Kim, Seul-Ki Mun, Ahmed A. Al-Karmalawy, Radwan Alnajjar, Yu-Jeong Choi, Jong-Jin Kim, Ghilsoo Nam, Hoon Kim & Gyochang Keum. (2024) Novel coumarin benzamides as potent and reversible monoamine oxidase-B inhibitors: Design, synthesis, and neuroprotective effects. Bioorganic Chemistry 142, pages 106939.
Crossref
Shaik Mahammad Ghouse, Kareena Sinha, Alessandro Bonardi, Gaurav Pawar, Satyaveni Malasala, Srikanth Danaboina, Arifuddin Mohammed, Venkata M. Yaddanapudi, Claudiu T. Supuran & Srinivas Nanduri. (2023) 6‐Aminocoumarin oxime‐ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies. Archiv der Pharmazie 356:10.
Crossref
Mónica Martínez-Montiel, Laura L. Romero-Hernández, Simone Giovannuzzi, Paloma Begines, Adrián Puerta, Ana I. Ahuja-Casarín, Miguel X. Fernandes, Penélope Merino-Montiel, Sara Montiel-Smith, Alessio Nocentini, José M. Padrón, Claudiu T. Supuran, José G. Fernández-Bolaños & Óscar López. (2023) Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors. International Journal of Molecular Sciences 24:11, pages 9401.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.